Zika virus – emergence,evolution, pathology,diagnosis, and control: current global scenario and future perspectives – a comprehensive review

This review converses the Zika virus which has attained global concern due to its rapid pandemic potential and impact on humans. Though Zika virus was first isolated in 1947, till the recent large-scale outbreak which occurred in Micronesia, in 2007, the virus was placed into the innocuous pathogen category. The World Health Organization on 1 February 2016 declared it as a ‘Public Health Emergency of International Concern.’ Of the note, American as well as Pacific Island strains/isolates is relatively closer to Asian lineage strains. The African and American strains share more than 87.5% and 95% homologies with Asian strains/isolates, respectively. Asian strains form independent clusters, except those isolated from China, suggesting relatively more diversity than African strains. Prevention and control are mainly aimed at the vector population (mosquitoes) with Aedes aegypti being the main species. Surveys in Africa and Asia indicated seropositivity in various animal species. However, so far its natural reservoir is unknown. There is an urgent need to understand why Zika virus has shifted from being a virus that caused mild illness to unforeseen birth defects as well as autoimmune-neurological problems. Unfortunately, an effective vaccine is not available yet. Availability of cryo-electron microscopy based on 3.8 Å resolution revealing mature Zika virus structure and the probable virus attachment site to host cell would provide critical insights into the development of antiviral treatments and vaccines.     

Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007

Equine influenza virus (EIV) surveillance is important in the management of equine influenza. It provides data on circulating and newly emerging strains for vaccine strain selection. To this end, antigenic characterisation by haemaggluttination inhibition (HI) assay and phylogenetic analysis was carried out on 28 EIV strains isolated in North America and Europe during 2006 and 2007. In the UK, 20 viruses were isolated from 28 nasopharyngeal swabs that tested positive by enzyme-linked immunosorbent assay. All except two of the UK viruses were characterised as members of the Florida sublineage with similarity to A/eq/Newmarket/5/03 (clade 2). One isolate, A/eq/Cheshire/1/06, was characterised as an American lineage strain similar to viruses isolated up to 10 years earlier. A second isolate, A/eq/Lincolnshire/1/07 was characterised as a member of the Florida sublineage (clade 1) with similarity to A/eq/Wisconsin/03. Furthermore, A/eq/Lincolnshire/1/06 was a member of the Florida sublineage (clade 2) by haemagglutinin (HA) gene sequence, but appeared to be a member of the Eurasian lineage by the non-structural gene (NS) sequence suggesting that reassortment had occurred. A/eq/Switzerland/P112/07 was characterised as a member of the Eurasian lineage, the first time since 2005 that isolation of a virus from this lineage has been reported. Seven viruses from North America were classified as members of the Florida sublineage (clade 1), similar to A/eq/Wisconsin/03. In conclusion, a variety of antigenically distinct EIVs continue to circulate worldwide. Florida sublineage clade 1 viruses appear to predominate in North America, clade 2 viruses in Europe.     

Seroprevalence of antibodies against bovine leukemia virus, bovine viral diarrhea virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum in dairy cattle in Saskatchewan

Blood was drawn from 1530 dairy cows in 51 herds. For antibodies against bovine leukemia virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum, 37.4%, 2.7%, and 5.6% of cows were test positive, respectively, while 29.2% of herds had unvaccinated animals with > or = 1:64 for bovine viral diarrhea virus.     

Advances in therapeutic and managemental approaches of bovine mastitis: a comprehensive review

Mastitis (intramammary inflammation) caused by infectious pathogens is still considered a devastating condition of dairy animals affecting animal welfare as well as economically incurring huge losses to the dairy industry by means of decreased production performance and increased culling rates. Bovine mastitis is the inflammation of the mammary glands/udder of bovines, caused by bacterial pathogens, in most cases. Routine diagnosis is based on clinical and subclinical forms of the disease. This underlines the significance of early and rapid identification/detection of etiological agents at the farm level, for which several diagnostic techniques have been developed. Therapeutic regimens such as antibiotics, immunotherapy, bacteriocins, bacteriophages, antimicrobial peptides, probiotics, stem cell therapy, native secretory factors, nutritional, dry cow and lactation therapy, genetic selection, herbs, and nanoparticle technology-based therapy have been evaluated for their efficacy in the treatment of mastitis. Even though several strategies have been developed over the years for the purpose of managing both clinical and subclinical forms of mastitis, all of them lacked the efficacy to eliminate the associated etiological agent when used as a monotherapy. Further, research has to be directed towards the development of new therapeutic agents/techniques that can both replace conventional techniques and also solve the problem of emerging antibiotic resistance. The objective of the present review is to describe the etiological agents, pathogenesis, and diagnosis in brief along with an extensive discussion on the advances in the treatment and management of mastitis, which would help safeguard the health of dairy animals.     

Nutrients,amino acid,fatty acid and non‐starch polysaccharide profile and in vitro digestibility of macadamia nut cake in swine

The highly variable cost and limited availability of conventional feedstuffs make it imperative to explore alternative feedstuffs to be used in swine. Macadamia nut cake (MNC), a coproduct of the macadamia nut oil industry, has not been well studied. MNC was analyzed for its nutrient profile, gross energy (GE), fibers, amino acids and fatty acids content. Dry matter (DM) and GE digestibility of MNC in swine was determined using an in vitro model. On a DM basis, ash, crude protein, ether extract, NDF, ADF, lignin and GE were found to be 3.7, 25.5, 11.9, 35.8, 28.0, 16.0% and 5581 kcal/kg, respectively. Total and soluble non‐starch polysaccharide content were 32.2 and 11.8%, respectively. The concentration of lysine was found to be 0.7%. The DM and GE digestibility were found to be 75.7 and 71.4%, respectively. Gross energy content of MNC is comparable with that of corn and higher than soybean meal, while protein content is twice as high as corn but lower than soybean meal. In conclusion, MNC is not merely a good source of protein and energy but also has fairly high digestibility in swine. Hence, it can be used as a viable alternative source of energy and protein in swine diets.     

Salt-tolerant rhizobacteria-mediated induced tolerance in wheat (<Emphasis Type="Italic">Triticum aestivum</Emphasis>) and chemical diversity in rhizosphere enhance plant growth

Salt-tolerant isolates Bacillus pumilus, Pseudomonas mendocina, Arthrobacter sp., Halomonas sp., and Nitrinicola lacisaponensis isolated from high saline habitats exhibited plant growth-promoting traits like P solubilization and indole acetic acid (IAA), siderophore, and ammonia production. These isolates were inoculated in wheat to assess microbe-mediated responses and plant growth promotion in salt affected soil. Maximum shoot and root length (33.8 and 13.6 cm) and shoot and root biomass (2.73 and 4.48 g dry weight) was recorded in plants inoculated with B. pumilus after 30 days. Total chlorophyll content was maximum in the leaves of the plants treated with Halomonas sp. (24.22 mg g⁻¹ dry weight) followed by B. pumilus (23.41 mg g⁻¹ dry weight) as compared to control (18.21 mg g⁻¹ dry weight) after 30 days. Total protein content was maximum in Arthrobacter sp. inoculated plant leaves (3.19 mg g⁻¹ dry weight) followed by B. pumilus (2.47 mg g⁻¹ dry weight) as compared to control (2.15 mg g⁻¹ dry weight) after 30 days. Total carotenoid content was maximum in plants inoculated with Halomonas sp. (1,075.45 and 1,113.29 μg g⁻¹ dry weight) in comparison to control (837.32 and 885.85 μg g⁻¹ dry weight) after 15 and 30 days. Inoculation of bacterial isolates increased presence of individual phenolics (gallic, caffeic, syringic, vanillic, ferulic, and cinnamic acids) and flavonoid quercetin in the rhizosphere soil. The concentration of IAA in rhizosphere soil and root exudates was also higher in all treatments than in control. Accumulation of phenolics and quercetin in the plants played a cumulative synergistic role that supported enhanced plant growth promotion of wheat in the stressed soil.     

Studies on arsenite-arsenate system adsorption of arsenate

The arsenic content of soils varies from 0.3–40 p.p.m., but in plants it is rather stationary, being 3 p.p.m.¹⁾ However arsenites and arsenates have been used since long ago as insecticides and herbicides respectively, and hence sometimes large amounts of arsenic are detected in soils where arsenicals have been sprayed continuously. The arsenite-arsenate relations in soils are of particular interest because arsenite arsenic is more toxic to plants than arsenate arsenic.     

Delivering rust resistant wheat to farmers: a step towards increased food security

An important step towards reducing the vulnerability of wheat in Africa and Asia to the Ug99 race of the stem rust pathogen is the substitution of current susceptible varieties with superior resistant varieties. In the 2008?C2009 cropping season both seed multiplication and dissemination of Ug99 resistant varieties were initiated in Afghanistan, Bangladesh, Egypt, Ethiopia, Iran, India, Nepal and Pakistan. Ug99 resistant varieties must occupy about 5% of the area sown to wheat in each country to ensure sufficient seed to displace current popular varieties. Because of the underdeveloped seed industry and small farm sizes in most of these countries, various strategies are being applied for rapid multiplication and dissemination of resistant varieties. Approaches being used include pre-release seed multiplication while candidate resistant lines are being tested in national evaluation trials and farmer participatory selection. Resistant varieties are already released in Afghanistan, Bangladesh, Egypt and Pakistan and more varieties are expected to be released in 2010 in these and other countries. Our results show that some new Ug99 resistant lines have yield superiority over dominant local varieties. Activities and progress in seed multiplication using existing and new Ug99 resistant varieties are discussed.     

Risk factors associated with Mycobacterium avium subspecies paratuberculosis seropositivity in Canadian dairy cows and herds

Our objective was to determine the risk factors associated with the seroprevalence of Mycobacterium avium subspecies paratuberculosis (MAP) in a large number of randomly selected Canadian dairy herds, controlling for important confounding variables and co-infections with bovine leukemia virus (BLV), bovine viral diarrhea virus (BVDV) and Neospora caninum (NC). Serum samples from 30 randomly selected cows, where available, in 315 herds from seven provinces were tested for antibodies against BLV, MAP and NC using commercially available enzyme-linked immunosorbant assay (ELISA) test kits, while five unvaccinated cattle >6 months old from each herd were tested for antibodies to BVDV. We used a zero-inflated negative-binomial (ZINB) multivariable model to determine simultaneously the risk factors associated with the count of MAP-seropositive cows in a herd, and the odds of herds having no MAP-seropositive cows as compared to having one or more MAP seropositive cows in a herd. The following factors were significantly positively associated with the count of MAP-seropositive cows: "more than one cow in the maternity pen", "group-housing for pre-weaned calves in winter", "open heifers purchased during the last 12 months", "beef cattle direct (nose-to-nose) contact", "BVDV-seropositive herds (> or = 1 animal with > or = 1:64 titer)" and "BVD vaccination not done properly in calves" (i.e. after 6 months old, animals were not boostered 2-4 weeks after their first killed vaccine, or not given modified live vaccine), with count ratios of 1.7, 2.0, 2.3, 1.9, 1.4 and 1.8, respectively. The variable "BVDV vaccination (modified live) done properly in calves" (i.e. received another modified live vaccination after 6 months as well) was associated with 0.4 times fewer MAP-seropositive cows.